Saccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Research in Microbiology

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.RESMIC.2005.11.007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• TNF-αneutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis

  2003cited by this paper
• Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells

  2003influential reference
• Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α

  2002cited by this paper
• Enterohemorrhagic Escherichia coli Infection Induces Interleukin-8 Production via Activation of Mitogen-Activated Protein Kinases and the Transcription Factors NF-κB and AP-1 in T84 Cells

  2002cited by this paper
• Death by necrosis

  2002cited by this paper
• Biotherapeutic agents in the treatment of infectious diarrhea.

  2001cited by this paper
• Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice

  2001cited by this paper
• Therapeutic effect of anti-TNF-alpha antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli O157 infection.

  2001cited by this paper
• Protection from gastrointestinal diseases with the use of probiotics.

  2001cited by this paper
• Enterohemorrhagic Escherichia coliInduces Apoptosis Which Augments Bacterial Binding and Phosphatidylethanolamine Exposure on the Plasma Membrane Outer Leaflet

  2000influential reference
• Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected T84 Cells

  2000cited by this paper
• Sustained Polymorphonuclear Leukocyte Transmigration Induces Apoptosis in T84 Intestinal Epithelial Cells

  2000cited by this paper
• The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

  2000cited by this paper
• Host Cell Death due to EnteropathogenicEscherichia coli Has Features of Apoptosis

  1999cited by this paper
• Synergistic effects of interferon γ and tumour necrosis factor α on T84 cell function

  1999cited by this paper
• Effect of Saccharomyces boulardii on cAMP- and Ca2+-dependent Cl- Secretion in T84 Cells

  1999cited by this paper
• Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa

  1999cited by this paper
• Diarrheagenic Escherichia coli

  1998cited by this paper
• Role of Tumor Necrosis Factor Alpha in Gnotobiotic Mice Infected with an Escherichia coli O157:H7 Strain

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Intracellular Signal Triggered by Cholera Toxin inSaccharomyces boulardii and Saccharomyces cerevisiae

  1998cited by this paper
• Apoptosis of human intestinal epithelial cells after bacterial invasion.

  1998influential reference
• Mitochondria and apoptosis.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha.

  1998cited by this paper
• Tumour necrosis factor and Crohn's disease.

  1997cited by this paper
• Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium.

  1997cited by this paper
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

  1997cited by this paper
• Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death.

  1997cited by this paper
• Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice

  1997cited by this paper
• Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.

  1996cited by this paper
• Role of verotoxin receptors in pathogenesis.

  1996cited by this paper
• Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum

  1996cited by this paper
• Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.

  1996cited by this paper
• Salmonella typhimurium invasion induces apoptosis in infected macrophages.

  1996cited by this paper
• In vivo apoptosis in Shigella flexneri infections

  1996cited by this paper
• Induction of gastric epithelial apoptosis by Helicobacter pylori.

  1996cited by this paper
• A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

  1995cited by this paper
• Protective effect of Saccharomyces boulardii against the cholera toxin in rats.

  1995cited by this paper
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

  1995cited by this paper
• Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen.

  1995cited by this paper
• Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

  1995cited by this paper
• Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis.

  1994cited by this paper
• A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

  1994cited by this paper
• Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

  1994cited by this paper
• Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.

  1994cited by this paper
• Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

  1993cited by this paper
• Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

  1993cited by this paper
• Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro

  1991cited by this paper
• Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures.

  1991cited by this paper
• Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.

  1990cited by this paper
• Escherichia coli 0157:H7-associated colitis: A clinical and histological study of 11 cases

  1990cited by this paper
• Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice

  1989cited by this paper
• Verotoxin receptor glycolipid in human renal tissue.

  1989cited by this paper
• Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor.

  1987cited by this paper
• Recombinant lymphokines and their receptors

  1987cited by this paper
• Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.

  1986cited by this paper
• Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

  1984cited by this paper

• The probiotic yeast Saccharomyces boulardii CNCM I-745 prevents autophagy in macrophages and epithelial cells infected with Vibrio parahaemolyticus

  2026cites this paper
• Evaluation of Single and Multi-Strain Probiotics with Gentamicin Against E. coli O157:H7: Insights from In Vitro and In Vivo Studies

  2025cites this paper
• Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component

  2022cites this paper
• Mitigation of antibiotic resistance using probiotics, prebiotics and synbiotics. A review

  2022cites this paper
• Dietary Management by Probiotics, Prebiotics and Synbiotics for the Prevention of Antimicrobial Resistance

  2021cites this paper
• Effect of Non-LAB Probiotics on Foodborne Enteric Pathogens: A Systematic Review

  2021cites this paper
• Antibiotic-free diet supplemented with live yeasts decreases inflammatory markers in the ileum of weaned piglets

  2020cites this paper
• An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer

  2020cites this paper
• Supplementation with Saccharomyces boulardii Increases the Maximal Oxygen Consumption and Maximal Aerobic Speed Attained by Rats Subjected to an Incremental-Speed Exercise

  2019cites this paper
• Protective effect of Lactobacillus delbrueckii subsp. Lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis

  2019cites this paper
• Developing a guide of bioinformatic database for probiotic products

  2019cites this paper
• Lactobacillus rhamnosus GG and Saccharomyces cerevisiae boulardii exert synergistic antipathogenic activity in vitro against enterotoxigenic Escherichia coli.

  2019cites this paper
• Saccharomyces- Eukaryotic Probiotic for Human Applications

  2019cites this paper
• Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis.

  2018cites this paper
• Efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the paediatric population: a systematic review

  2018cites this paper
• Saccharomyces boulardii CNCM I-745 beeinflusst das darmassoziierte Immunsystem

  2017cites this paper
• Cellular and molecular effects of yeast probiotics on cancer

  2017cites this paper
• Secretion metabolites of probiotic yeast, Pichia kudriavzevii AS-12, induces apoptosis pathways in human colorectal cancer cell lines.

  2017cites this paper
• Probiotic Yeasts in Human Welfare

  2017cites this paper
• Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?

  2017cites this paper
• Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies

  2016cites this paper
• Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system

  2016cites this paper
• Probiotics, Prebiotics, Synbiotics, and Foodborne Illness

  2016cites this paper
• A systematic review of the efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the pediatric population

  2016cites this paper
• Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?

  2015cites this paper
• The effect of Saccharomyces boulardii in patients eligible for liver transplantation.

  2015cites this paper
• Survie et pathogénicité des EHEC dans l'environnement digestif : Interactions avec le microbiote et l'épithélium intestinal. : Influence de l'administration de levures probiotiques.

  2015cites this paper
• Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer’s patches

  2015cites this paper
• Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells

  2014cites this paper
• Etude en systèmes digestifs artificiels de la survie et de la pathogénicité des Escherichia Coli entérohémorragiques (EHEC). Influence de la matrice alimentaire et de l'administration de souches probiotiques.

  2014cites this paper
• Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract

  2014cites this paper
• Role of Endogenous Microbiota, Probiotics and Their Biological Products in Human Health

  2013cites this paper
• Bacillus amyloliquefaciens SC06 inhibits ETEC-induced pro-inflammatory responses by suppression of MAPK signaling pathways in IPEC-1 cells and diarrhea in weaned piglets

  2013cites this paper
• A pilot study on the effects of a yeast probiotic on sow and piglet behavior and well-being

  2013cites this paper
• Probiotic-derived factors for the treatment and prevention of 5-fluorouracil-induced intestinal mucositis.

  2013cites this paper
• Modern Approaches in Probiotics Research to Control Foodborne Pathogens

  2012cites this paper
• Human intestinal epithelial cell-derived molecule(s) increase enterohemorrhagic Escherichia coli virulence.

  2012cites this paper
• Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

  2012influential citation
• Saccharomyces boulardii Improves Intestinal Epithelial Cell Restitution by Inhibiting αvβ5 Integrin Activation State

  2012cites this paper
• Antimicrobial and Probiotic Properties of Yeasts: From Fundamental to Novel Applications

  2012cites this paper
• PROBIOTIC EFFECTS OF SACCHAROMYCES CEREVISIAE ON LAYING CHICKEN FED PALM KERNEL CAKE-BASED DIETS.

  2012influential citation
• Enterohemorrhagic Escherichia coli O157:H7 Survival in an In Vitro Model of the Human Large Intestine and Interactions with Probiotic Yeasts and Resident Microbiota

  2012cites this paper
• Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.

  2012cites this paper
• Saccharomyces cerevisiae Modulates Immune Gene Expressions and Inhibits ETEC-Mediated ERK1/2 and p38 Signaling Pathways in Intestinal Epithelial Cells

  2011cites this paper
• Aberrant response of human myeloid dendritic cells to microbial stimuli in patients with inflammatory bowel disease

  2011cites this paper
• Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells.

  2011cites this paper
• Saccharomyces boulardii Improves Intestinal Cell Restitution through Activation of the α2β1 Integrin Collagen Receptor

  2011cites this paper
• Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis.

  2011cites this paper
• Evidence Supporting the use of Probiotics for the Prevention and Treatment of Chemotherapy-Induced Intestinal Mucositis

  2011influential citation
• [Recent advances in Saccharomyces boulardii research].

  2010cites this paper
• Progrès récents dans la recherche sur Saccharomyces boulardii

  2010cites this paper
• Beneficial Effects of Probiotic and Food Borne Yeasts on Human Health

  2010influential citation
• Über den therapeutischen Nutzen von Hefezellen-ein historischer Überblick

  2010cites this paper
• Probiotic bacteria and intestinal epithelial barrier function.

  2010cites this paper
• Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model

  2010cites this paper
• The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea

  2009cites this paper
• Saccharomyces boulardii in childhood

  2009cites this paper
• 2D PAGE: Sample Preparation and Fractionation

  2008cites this paper
• Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.

  2008cites this paper
• Heme Oxygenase-1 Is a Critical Regulator of Nitric Oxide Production in Enterohemorrhagic Escherichia coli-Infected Human Enterocytes

  2008cites this paper
• Heme Oxygenase-1 Is a Critical Regulator of Nitric Oxide Production in Enterohemorrhagic Escherichia coli-Infected Human Enterocytes1

  2008cites this paper
• Sample preparation procedure for cellular fungi.

  2008cites this paper
• Saccharomyces boulardii inhibits lipopolysaccharide‐induced activation of human dendritic cells and T cell proliferation

  2008cites this paper
• Review article: yeast as probiotics –Saccharomyces boulardii

  2007cites this paper
• article : yeast as probiotics – Saccharomyces boulardii

  2007cites this paper
• Modulation of the gastrointestinal barrier function by probiotic Escherichia coli Nissle 1917

  2006cites this paper
• Clinical and Experimental Gastroenterology Dovepress

  year unknowncites this paper